Grown Rogue International (GRUSF) Other Operating Expenses (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Other Operating Expenses of $154994.0 in Q1 2026, up 100.0% quarter-over-quarter from -$2324.3 billion in Q4 2025.
Grown Rogue International (GRUSF) Other Operating Expenses (2009 - 2026) Analysis & Trends
Grown Rogue International's Other Operating Expenses history runs 16 years deep, the most recent figure standing at $154994.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses changed N/A year-over-year to $154994.0; the TTM figure through Mar 2026 stood at -$1796.9 billion (changed N/A YoY), while the FY2025 annual figure was $3.1 million, up 59.71% from the prior year.
- Other Operating Expenses was $154994.0 for Q1 2026 at Grown Rogue International, up from -$2324.3 billion in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $527.4 billion in Q3 2025 to a low of -$7797.7 billion in Q4 2024.
- Historically, Other Operating Expenses has averaged -$738.0 billion across 5 years, with a median of $118450.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses slumped 15696517447.81% in 2024, then jumped 41199688.06% in 2025.
- A 5-year view of Other Operating Expenses shows it stood at -$5440.0 in 2022, then jumped by 1013.2% to $49678.0 in 2023, then plunged by 15696517447.81% to -$7797.7 billion in 2024, then surged by 70.19% to -$2324.3 billion in 2025, then surged by 100.0% to $154994.0 in 2026.
- The last three Other Operating Expenses figures came in at $154994.0 (Q1 2026), -$2324.3 billion (Q4 2025), and $527.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 154,994.00 |
| Dec 31, 2025 | -2,324.26 Bn |
| Sep 30, 2025 | 527.39 Bn |
| Dec 31, 2024 | -7,797.72 Bn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 118,450.00 |
| Dec 31, 2023 | 49,678.00 |
| Oct 31, 2023 | 71,725.71 |
| Jul 31, 2023 | 72,678.45 |
| Apr 30, 2023 | 169,923.00 |
| Jan 31, 2023 | 223,774.00 |
| Jan 31, 2022 | -5,440.00 |
| Apr 30, 2021 | 413,651.00 |
| Jan 31, 2021 | 390,397.00 |
| Oct 31, 2020 | 267,077.00 |
| Apr 30, 2020 | 78,031.00 |
| Jan 31, 2020 | 110,446.00 |
| Oct 31, 2019 | 98,174.00 |
| Jul 31, 2019 | -6,702.00 |